Venous Thromboembolism:グローバル臨床試験レビューH1, 2013...市場調査レポートについてご紹介

【英文タイトル】Venous Thromboembolism Global Clinical Trials Review, H1, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Venous Thromboembolism 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Venous Thromboembolism 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Venous Thromboembolism Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Bayer AG 33
Clinical Trial Overview of Bayer AG 33
Sanofi 35
Clinical Trial Overview of Sanofi 35
Astellas Pharma Inc. 37
Clinical Trial Overview of Astellas Pharma Inc. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Boehringer Ingelheim GmbH 39
Clinical Trial Overview of Boehringer Ingelheim GmbH 39
Daiichi Sankyo Company, Limited 40
Clinical Trial Overview of Daiichi Sankyo Company, Limited 40
Bristol-Myers Squibb Company 41
Clinical Trial Overview of Bristol-Myers Squibb Company 41
AstraZeneca PLC 42
Clinical Trial Overview of AstraZeneca PLC 42
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Portola Pharmaceuticals, Inc. 44
Clinical Trial Overview of Portola Pharmaceuticals, Inc. 44
Daiichi Sankyo, Inc. 45
Clinical Trial Overview of Daiichi Sankyo, Inc. 45
Boehringer Ingelheim Pharmaceuticals, Inc. 46
Clinical Trial Overview of Boehringer Ingelheim Pharmaceuticals, Inc. 46
Isis Pharmaceuticals, Inc. 47
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 47
LEO Pharma A/S 48
Clinical Trial Overview of LEO Pharma A/S 48
ThromboGenics NV 49
Clinical Trial Overview of ThromboGenics NV 49
Eisai Inc. 50
Clinical Trial Overview of Eisai Inc. 50
MEDRAD Interventional/POSSIS 51
Clinical Trial Overview of MEDRAD Interventional/POSSIS 51
EPIX Pharmaceuticals, Inc. (Inactive) 52
Clinical Trial Overview of EPIX Pharmaceuticals, Inc. (Inactive) 52
ARYx Therapeutics, Inc. 53
Clinical Trial Overview of ARYx Therapeutics, Inc. 53
Medco Health Solutions Inc. (Inactive) 54
Clinical Trial Overview of Medco Health Solutions Inc. (Inactive) 54
Clinical Trial Overview of Top Universities / Institutes / Hospitals 55
Ottawa Hospital Research Institute 55
Clinical Trial Overview of Ottawa Hospital Research Institute 55
Utrecht University 56
Clinical Trial Overview of Utrecht University 56
University of Calgary 57
Clinical Trial Overview of University of Calgary 57
University of Padua 58
Clinical Trial Overview of University of Padua 58
The University of Utah 59
Clinical Trial Overview of The University of Utah 59
Mayo Clinic 60
Clinical Trial Overview of Mayo Clinic 60
Brigham and Women’s Hospital 61
Clinical Trial Overview of Brigham and Women’s Hospital 61
Università degli Studi dell’Insubria 62
Clinical Trial Overview of Università degli Studi dell’Insubria 62
Johann Wolfgang Goethe University Hospitals 63
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 63
Stanford University 64
Clinical Trial Overview of Stanford University 64
The University of Texas M. D. Anderson Cancer Center 65
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 65
Leiden University Medical Center 66
Clinical Trial Overview of Leiden University Medical Center 66
Hadassah Medical Organization 67
Clinical Trial Overview of Hadassah Medical Organization 67
Odense University Hospital 68
Clinical Trial Overview of Odense University Hospital 68
McMaster University 69
Clinical Trial Overview of McMaster University 69
Centre Hospitalier Universitaire de Saint Etienne 70
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 70
University of Zurich 71
Clinical Trial Overview of University of Zurich 71
St. Joseph’s Healthcare Hamilton 72
Clinical Trial Overview of St. Joseph’s Healthcare Hamilton 72
The University of Vermont 73
Clinical Trial Overview of The University of Vermont 73
University of Perugia 74
Clinical Trial Overview of University of Perugia 74
Five Key Clinical Profiles 75
Appendix 133
Abbreviations 133
Definitions 133
Research Methodology 134
Secondary Research 135
About GlobalData 135
Contact Us 135
Disclaimer 135
Source 136


【レポート販売概要】

■ タイトル:Venous Thromboembolism:グローバル臨床試験レビューH1, 2013
■ 英文:Venous Thromboembolism Global Clinical Trials Review, H1, 2013
■ 発行日:2013年2月15日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160421
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。